In addition, PLD has a good passive targeting effect, and its mechanism is to enhance the permeation and retention (EPR) effect, so the drug concentration of PLD in tumour tissue is dozens of times higher than that in normal tissue, thereby enhancing the anti-tumour effect of PLD. This evidence concerns the gene GPLD1 and neoplasm.